MENU
IMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
I-MAB (IMAB) Ownership - Who owns I-MAB?
Profile
Industry
N/A
Address
555 West Haiyang Road
Phone
+86 2160578000
Employees
318
Web
https://www.i-mabbiopharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
73.51M
P/E Ratio
N/A
Total Cash
184.39M
Projected Growth
N/A
Total Debt
3.78M
Revenue
3.27M
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash/Share
2.26
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
IMAB
Capitalization
73.5M
P/E Ratio
N/A
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash
184M
Total Cash/Share
2.26
Total Debt
3.78M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
3.27M
ROE
N/A
Book Value
218M
P/B Ratio
0.34
Cash Flow
N/A
Earnings
-0.97
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
19K
Current Ratio
15.99
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-212.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.43
Shares Held By Institutions
25.3M
Shares Outstanding - Current
81.5M
Total Liabilities
14.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-50.247
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
555 West Haiyang Road
Phone
+86 2160578000
Employees
318
Web
https://www.i-mabbiopharma.com